Canlyniadau Chwilio - Tal-Singer R

Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts gan Mannino DM, Müellerova H, Valvi D, Tal-Singer R

Cael y testun llawn

Clinical Meaningfulness of the Composite Endpoint, COPDCompEx, in Defining Exacerbations and Worsening of COPD: A Post Hoc Analysis of 4 Clinical Interventional Studies of COPD gan Tal-Singer R, Vogelmeier CF, Bolton C, Bengtsson T, Peterson S, Sidaway M, Da Silva CA

Cael y testun llawn

Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. gan Dubin, G, Basu, S, Mallory, D L, Basu, M, Tal-Singer, R, Friedman, H M

Cael y testun llawn
Cael y testun llawn
Cael y testun llawn

Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider I... gan Román-Rodríguez M, McMullan I, Warner M, Compton CH, Tal-Singer R, Orlow JM, Han MK

Cael y testun llawn

Treatment decisions: insights from people with asthma or COPD and their healthcare providers on disease and treatment decisions gan Tal-Singer R, Román-Rodríguez M, McMullan I, Warner M, Compton C, Orlow JM, Han MK

Cael y testun llawn

Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. gan Tal-Singer, R, Lasner, T M, Podrzucki, W, Skokotas, A, Leary, J J, Berger, S L, Fraser, N W

Cael y testun llawn
Cael y testun llawn
Cael y testun llawn

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk gan Langholm LL, Rønnow SR, Sand JMB, Leeming DJ, Tal-Singer R, Miller BE, Vestbo J, Karsdal MA, Manon-Jensen T

Cael y testun llawn

Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. gan Tal-Singer, R, Peng, C, Ponce De Leon, M, Abrams, W R, Banfield, B W, Tufaro, F, Cohen, G H, Eisenberg, R J

Cael y testun llawn
Cael y testun llawn
Cael y testun llawn

Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study gan Kaise T, Sakihara E, Tamaki K, Miyata H, Hirahara N, Kirichek O, Tawara R, Akiyama S, Katsumata M, Haruya M, Ishii T, Simard EP, Miller BE, Tal-Singer R

Cael y testun llawn

A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study gan Shinoda M, Hataji O, Miura M, Kinoshita M, Mizoo A, Tobino K, Soutome T, Nishi T, Ishii T, Miller BE, Tal-Singer R, Tomlinson R, Matsuki T, Jones PW, Shibata Y

Cael y testun llawn

Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey Results gan Tal-Singer R, Willard KS, Luttmann MA, Sprankle M, Reynolds J, Muerza Santos I, Jaffee H, Vichiendilokkul A, Jacomelli C, Novak Š, Gascon Moreno V, Wise RA

Cael y testun llawn

Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene® Study gan Li Y, Ragland M, Austin E, Young K, Pratte K, Hokanson JE, Beaty TH, Regan EA, Rennard SI, Wern C, Jacobs MR, Tal-Singer R, Make BJ, Kinney GL

Cael y testun llawn

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort gan Stott-Miller M, Müllerová H, Miller B, Tabberer M, El Baou C, Keeley T, Martinez FJ, Han M, Dransfield M, Hansel NN, Cooper CB, Woodruff P, Ortega VE, Comellas AP, Paine R III, Kanner RE, Anderson W, Drummond MB, Kim V, Tal-Singer R, Lazaar AL

Cael y testun llawn